Recurrence: all 3,523 studies
Page 34 of 36. Open to participants first (870), then studies with results posted, then the rest; newest registration first within each.
- Bortezomib and Dexamethasone as Treatment and Maintenance for Multiple Myeloma RelapseCompletedNCT00335348Phase 2
- A Study of Letrozole in the Treatment of Endometrial CancerCompletedNCT00333086Phase 2
- Safety and Tolerability Study of FolateImmune in Combination With Cytokines in Patients With Refractory or Metastatic CancerCompletedNCT00329368Phase 1
- Short-Term Versus Long-Term Treatment for Severe Premenstrual Syndrome (PMS)CompletedNCT00318773Phase 4
- Effect of Clonidine on Responses to Imagery ScriptsCompletedNCT00318760Phase 1
- Doxil and Gemcitabine in Recurrent Ovarian CancerTerminatedNCT00312650Phase 2
- Recurrent Abdominal Pain in Childhood -Characteristics and CourseCompletedNCT00311233
- Safety and Dose Study of GRN163L Administered to Patients With Refractory or Relapsed Solid Tumor MalignanciesCompletedNCT00310895Phase 1
- Study of Photodynamic Therapy in Patients With Prostate Cancer Following Radiation TherapyCompletedNCT00308919Phase 2
- Study of Vintafolide (MK-8109, EC145) for the Treatment of Recurrent or Refractory Solid Tumors (MK-8109-006, EC-FV-01)CompletedNCT00308269Phase 1
- Intravenous Immunoglobulin After Relapse in VasculitisTerminatedNCT00307658Phase 3
- RATTRAP: Infliximab Versus Rituximab in Systemic Necrotizing VasculitidesCompletedNCT00307593Not applicable
- Evaluation of Lenalidomide, Doxorubicin and Dexamethasone (RAD) in Patients With Relapsed or Refractory Multiple MyelomaCompletedNCT00306813Phase 1/2
- Donor Stem Cell Transplant Followed By Donor White Blood Cell Infusions in Treating Young Patients With Hematologic CancerTerminatedNCT00301860Not applicable
- Study for Patients With Chronic HCV (GT 1 or 3) Who Relapsed to Previous (Peg)Interferon/ Ribavirin Combination TherapyStatus unknownNCT00299923Phase 3
- Donor Stem Cell Transplant in Treating Patients With Hematologic Cancer, Metastatic Kidney Cancer, or Aplastic AnemiaStatus unknownNCT00295997Not applicable
- Trial of TP Versus TC Regimens for Stage IVb, Persistent, or Recurrent Cervical Cancer (JCOG0505, CC-TPTC-P3)CompletedNCT00295789Phase 3
- Clonidine for Relapse Prevention in Buprenorphine-Maintenance PatientsCompletedNCT00295308Phase 1
- Donor Umbilical Cord Blood Transplant in Treating Patients With Hematologic CancerTerminatedNCT00290628Not applicable
- Correlation of the Chemoresponse Assay With PFS in Patients With Recurrent Epithelial Ovarian, Peritoneal, or Fallopian Tube CancerTerminatedNCT00288275
- Necessity of Esophageal Dissection During Laparoscopic FundoplicationCompletedNCT00287612Not applicable
- A Phase II Study of MDX-060 in Subjects With Relapsed or Refractory Hodgkin's DiseaseCompletedNCT00284804Phase 2
- Study of XL999 in Patients With Previously Treated Ovarian CancerTerminatedNCT00277290Phase 2
- Active Symptom Control Alone Or In Combination With Oral Topotecan In Patients With Relapsed Resistant Small Cell Lung CancerCompletedNCT00276276Phase 3
- A Telephone Feedback System for Prevention of Chronic Pain RelapseCompletedNCT00266773Not applicable
- D-dimer Levels During and After Anticoagulation in Patients With a Previous Venous Thromboembolism: Effects on the Risk of RecurrenceCompletedNCT00266045
- Laboratory-Treated Donor Bone Marrow in Treating Patients Who Are Undergoing a Donor Bone Marrow Transplant for Hematologic CancerCompletedNCT00265837Phase 3
- D-dimer to Establish Duration of Anticoagulation After Venous ThromboembolismCompletedNCT00264277Phase 4
- Patupilone Versus Doxorubicin in Patients With Ovarian, Primary Fallopian, or Peritoneal CancerCompletedNCT00262990Phase 3
- Bortezomib, Rituximab and Dexamethasone (BORID) for Relapsed/Refractory Mantle Cell LymphomaStatus unknownNCT00261612Phase 2
- Understanding Risk Factors Involved in Developing a Second Blood Clot.Status unknownNCT00261014
- Retarded Phosphatidylcholine Versus Mesalazin in Remission of Ulcerative Colitis.WithdrawnNCT00259571Phase 2/3
- G-CSF-Treated Donor Bone Marrow Transplant in Treating Patients With Hematologic DisordersTerminatedNCT00253552Not applicable
- Phase II Study of Aerosolized Liposomal 9-Nitro-20 (S)- Camptothecin (L9NC)CompletedNCT00249990Phase 2
- NB1011 Administered by Continuous Infusion in Cancers That Overexpress Thymidylate Synthase (TS)CompletedNCT00248404Phase 1/2
- Weekly Carboplatin and Taxotere in Platinum Sensitive Relapsed Ovarian or Tubal or Primary Peritoneal CancersTerminatedNCT00247988Phase 2
- Pilot Test of ACTOS in Multiple Sclerosis: Safety and TolerabilityCompletedNCT00242177Phase 1
- Study of Colchicine to Treat and Prevent Recurrent Pericarditis After Failure of Conventional Treatment.CompletedNCT00235079Phase 4
- Postoperative Adjuvant Therapy With Recombinant Interferon-Alpha Following Curative Resection of HCCCompletedNCT00234182Phase 1/2
- A Trial of Gemtuzumab Ozogamicin (GO) in Combination With Zosuquidar in Patients With CD33 Positive Acute Myeloid LeukemiaCompletedNCT00233909Phase 1/2
- Efficacy Study of Weekly Taxotere and Topotecan for Recurrent Gynecologic (GYN) CancersCompletedNCT00231855Phase 2
- Study of Rasburicase as Treatment or Prevention of Hyperuricemia Associated With Tumor Lysis Syndrome in Patients With Relapsed or Refractory Lymphoma, Leukemia, or Solid Tumor MalignancyCompletedNCT00230217Phase 4
- Psychosocial Treatment for Improving Chances of Survival in Women With Breast CancerCompletedNCT00226928Not applicable
- New Medications to Treat Alcohol DependenceCompletedNCT00223639Phase 2
- Enhancing Tobacco Abstinence Following HospitalizationCompletedNCT00222703Not applicable
- PREvent First Episode Relapse (PREFER)Status unknownNCT00220714Phase 4
- Evaluation of a New Therapeutic Strategy in Early and Active Relapsing-Remitting Multiple SclerosisTerminatedNCT00219908Phase 2
- Vorinostat With or Without Isotretinoin in Treating Young Patients With Recurrent or Refractory Solid Tumors, Lymphoma, or LeukemiaCompletedNCT00217412Phase 1
- Zoledronic Acid (ZOMETA) With Cyclophosphamide With Neuroblastoma and Cortical Bone InvolvementCompletedNCT00206388Phase 1
- Treatment of Relapsed T-cell Acute Lymphoblastic Leukemia or T-lymphoblastic Lymphoma With MabCampathCompletedNCT00199030Phase 2
- Treatment Protocol for Relapsed Acute Promyelocytic Leukemia (APL) With ArsenicStatus unknownNCT00196768Phase 4
- Addition of Herceptin to a Carboplatin-Paclitaxel Regimen in Patients With Ovarian CancerTerminatedNCT00189579Phase 2
- Everolimus for Treating Pediatric Patients With Recurrent or Refractory TumorsCompletedNCT00187174Phase 1
- Prophylactic Treatment of Episodic Cluster HeadacheCompletedNCT00184587Phase 2
- A Multi-site Trial Comparing Lichtensteins Operation and Prolene Hernia System in Inguinal HErnia RepairCompletedNCT00184483Not applicable
- Preventing Depression Relapse With Mindfulness-Based Cognitive TherapyCompletedNCT00183560Phase 4
- Rituximab in Children and Adolescents With Relapsed and Refractory B-Cell NHL/L3ALLTerminatedNCT00180895Phase 2
- Web-based Support for People With Schizophrenia and Their FamiliesCompletedNCT00177983Not applicable
- Phase I Trial of Biweekly Gemcitabine & Paclitaxel & Low-Dose Radiation for Metastatic or Recurrent Head & Neck CancerTerminatedNCT00176241Phase 1
- Exogenous Reinfection of Tuberculosis in TaiwanCompletedNCT00173433
- Letrozole in the Treatment of Advanced or Recurrent Hormone Receptor Positive Endometrial CancerCompletedNCT00171808Phase 2
- Fludarabine, Mitoxantrone and Rituximab in Relapsed or Primary Failing Advanced Follicular Non-Hodgkin's LymphomaCompletedNCT00169208Phase 2
- Donor Lymphocyte Infusion (DLI) for Relapsed (Post Transplant) LeukemiaCompletedNCT00167167Not applicable
- A Phase II/III Clinical Study on Inhibitory Effects of E0167 on Recurrence of Hepatocellular CarcinomaTerminatedNCT00165633Phase 2/3
- Irradiated Donor Lymphocyte Infusion in Treating Patients With Relapsed or Refractory Hematologic Cancer or Solid TumorCompletedNCT00161187Phase 1
- G207 Followed by Radiation Therapy in Malignant GliomaCompletedNCT00157703Phase 1
- A Phase I Trial of HDFL48 in Recurrent or Metastatic Colorectal CancersCompletedNCT00155558Phase 1
- Paclitaxel-HDFL for Locally Advanced and Recurrent/Metastatic Gastric CancersCompletedNCT00154726Phase 2
- Study of Bortezomib (Velcade) in Combination With Dexamethasone to Treat Patients With Relapsed Hodgkin's LymphomaTerminatedNCT00148018Phase 2
- The Role of Fluorothymidine Positron Emission Tomography (FLT-PET) in Proliferation of Colorectal Liver MetastasesTerminatedNCT00145665Phase 1/2
- Multicentre Trial to Evaluate the Safety and Efficacy of CP-316,311 in Major Depressive DisorderTerminatedNCT00143091Phase 2
- Study of a New Laparoscopic Technique for Parastomal Hernia Repair With MeshWithdrawnNCT00138957Not applicable
- A Phase 2 Study of Velcade™ in Subjects With Relapsed or Refractory Follicular B-Cell LymphomaTerminatedNCT00136591Phase 2
- Impact of Smoking Cessation on Sleep - 5CompletedNCT00132821Phase 4
- Using Telephone Technology to Prevent Relapse After Alcoholism TreatmentCompletedNCT00132795Phase 2
- Prevention of Severe Anaemia in Gambian ChildrenCompletedNCT00131716Phase 3
- ATN-161 in Advanced Renal Cell CancerTerminatedNCT00131651Phase 2
- Candesartan in the Prevention of Relapsing Atrial FibrillationCompletedNCT00130975Phase 3
- Study for Patients With Relapsed or Refractory Acute Myeloid Leukemia (AML)TerminatedNCT00129948Phase 2
- Alemtuzumab (Campath-1H) Monoclonal Antibody in Patients With Relapsed and Resistant Classical Hodgkin's DiseaseWithdrawnNCT00129753Phase 2
- Zosuquidar in Combination With Daunorubicin and Cytarabine in Patients Ages 55-75 With Newly Diagnosed Acute Myeloid Leukemia (AML)CompletedNCT00129168Phase 1/2
- Study of Colchicine to Treat Acute Pericarditis and Prevent RecurrencesCompletedNCT00128453Phase 3
- Study of Colchicine to Prevent the Postpericardiotomy SyndromeCompletedNCT00128427Phase 3
- Study of Colchicine to Treat and Prevent Recurrent Pericarditis (First Episode)CompletedNCT00128414Phase 3
- Cladribine, Cytarabine and Idarubicin in Patients With Relapsed Acute Myelocytic Leukemia (AML)Status unknownNCT00126321Phase 2
- Study of Motexafin Gadolinium and Docetaxel for Advanced CancerCompletedNCT00120939Phase 1
- Donor Bone Marrow Transplant in Treating Young Patients With Cancer or a Non-Cancerous DiseaseCompletedNCT00118326Phase 1/2
- Picoplatin as Second-Line Therapy for Patients With Small Cell Lung CancerCompletedNCT00116610Phase 2
- Study of AEE788 in Patients With Recurrent/Relapse Glioblastoma Multiforme (GBM)CompletedNCT00116376Phase 1/2
- ALL-REZ BFM 2002: Multi-Center Study for Children With Relapsed Acute Lymphoblastic LeukemiaCompletedNCT00114348Phase 4
- Safety Study of IPI-504 in Patients With Relapsed and Relapsed Refractory Multiple MyelomaCompletedNCT00113204Phase 1
- Topotecan in Treating Young Patients With Neoplastic Meningitis Due to Leukemia, Lymphoma, or Solid TumorsTerminatedNCT00112619Phase 1
- Study of Oral Ridaforolimus (AP23573, MK-8669) to Treat Patients With Refractory or Advanced Malignancies (MK-8669-016 AM4)(COMPLETED)CompletedNCT00112372Phase 1
- Fast Assessment of Stroke and Transient Ischemic Attack to Prevent Early Recurrence (FASTER)CompletedNCT00109382Phase 2/3
- Pixantrone (BBR 2778) in Patients With Refractory Acute Myelogenous Leukemia (AML)CompletedNCT00106600Phase 1/2
- Gemcitabine Plus Carboplatin Versus Carboplatin Monotherapy in Patients With Advanced Ovarian CancerCompletedNCT00102414Phase 3
- Oxaliplatin and Irinotecan in Treating Young Patients With Refractory Solid Tumors or LymphomasCompletedNCT00101270Phase 1
- Oxaliplatin, Ifosfamide and Etoposide in Treating Young Patients With Recurrent or Refractory Solid Tumors or LymphomaTerminatedNCT00101205Phase 1
- A Notch Signalling Pathway Inhibitor for Patients With T-cell Acute Lymphoblastic Leukemia/Lymphoma (ALL)(0752-013)TerminatedNCT00100152Phase 1
- Ispinesib In Subjects With Platinum-Taxane-Refractory Or Resistant Relapsed Ovarian CancerCompletedNCT00097409Phase 2